Avalo Therapeutics, Inc. (AVTX)
19.26
-0.57
(-2.87%)
USD |
NASDAQ |
Aug 24, 16:00
19.26
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Debt to Equity Ratio : 0.005 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.005 |
| March 31, 2026 | 0.0341 |
| December 31, 2025 | 0.0292 |
| September 30, 2025 | 0.0279 |
| June 30, 2025 | 0.0256 |
| March 31, 2025 | 0.0228 |
| December 31, 2024 | 0.0219 |
| September 30, 2024 | 0.0718 |
| June 30, 2024 | -0.8047 |
| March 31, 2024 | -0.0181 |
| December 31, 2023 | 0.5344 |
| September 30, 2023 | 0.1356 |
| June 30, 2023 | -2.324 |
| March 31, 2023 | -3.499 |
| December 31, 2022 | -2.168 |
| September 30, 2022 | -9.661 |
| June 30, 2022 | -3.883 |
| March 31, 2022 | 5.936 |
| December 31, 2021 | 1.618 |
| September 30, 2021 | 0.8851 |
| June 30, 2021 | 0.9463 |
| March 31, 2021 | 0.1018 |
| December 31, 2020 | 0.1411 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.0919 |
| June 30, 2020 | 0.0716 |
| March 31, 2020 | 0.0493 |
| September 30, 2019 | 0.9078 |
| June 30, 2019 | 0.9347 |
| March 31, 2019 | 0.7155 |
| December 31, 2018 | 0.7355 |
| September 30, 2018 | 0.7895 |
| June 30, 2018 | 0.8027 |
| March 31, 2018 | 0.6255 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.1938 |
| March 31, 2017 | -3.505 |
| December 31, 2016 | 11.37 |
| September 30, 2016 | 5.436 |
| June 30, 2016 | 0.7184 |
| March 31, 2016 | 0.5396 |
| December 31, 2015 | 0.4251 |
| September 30, 2015 | -1.404 |
| June 30, 2015 | -1.835 |
| March 31, 2015 | -6.191 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Incyte Corp. | 0.006 |
| AbbVie, Inc. | -11.93 |
| Rezolute, Inc. | 0.0095 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 490.78M |
| Total Liabilities (Quarterly) | 42.12M |
| Shareholders Equity (Quarterly) | 448.66M |
| Current Ratio | 19.31 |
| Net Debt Paydown Yield | 0.01% |